There are 3397 resources available
1990MO - Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial
Presenter: Afshin Dowlati
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA25 and LBA26
Presenter: Karin Haustermans
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast
HER2+ breast cancer
Presenter: Ian Krop
Session: Optimal treatment sequence in metastatic breast cancer (mBC) in 2023
Resources:
Slides
Webcast
Treatment after progression on immunotherapy
Presenter: Alexandra Leary
Session: Integrating immunotherapy into the standard of care for cervical cancer
Resources:
Slides
Webcast
How to personalise neoadjuvant immunotherapy
Presenter: Christian Blank
Session: Is neoadjuvant immunotherapy a therapeutic platform for all tumour types?
Resources:
Slides
Webcast
Management of antibody-drug conjugates toxicities
Presenter: Joseph Gligorov
Session: Management of novel treatments’ toxicities
Resources:
Slides
Webcast
Managing progression after EGFR TKIs in EGFR-mutant lung cancer
Presenter: Myung-Ju Ahn
Session: Managing disease progression in oncogene-driven lung cancer
Resources:
Slides
Webcast
Invited Discussant 131O and 1O
Presenter: Elin Gray
Session: Proffered Paper session 2 - Basic Science and Translational research
Resources:
Slides
Webcast
Invited Discussant 1083MO and 1084MO
Presenter: Georgina Long
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Slides
Webcast
1881O - Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study
Presenter: Neeraj Agarwal
Session: Proffered Paper session 2 - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast